Ezzat AA - Search Results

1

E-SHAP: an effective treatment in selected patients with relapsed non-Hodgkin's lymphoma.

Ezzat AA, Khalifa F, Berry J, Khan B, Raja MA, Abdel-Warith A. Ezzat AA, et al. Ann Oncol. 1994 May;5(5):453-6. doi: 10.1093/oxfordjournals.annonc.a058879. Ann Oncol. 1994. PMID: 8075052 Free article.

2

A prospective study of VEC-POB and POCE chemotherapy in aggressive non-Hodgkin's lymphoma.

Ezzat AA, Raja MA, Berry J, Abd El-Warith A, Khan BA, Rhydderch DC. Ezzat AA, et al. Am J Clin Oncol. 1997 Apr;20(2):179-83. doi: 10.1097/00000421-199704000-00016. Am J Clin Oncol. 1997. PMID: 9124196 Clinical Trial.

3

Primary gastric non-Hodgkin's lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma.

Ibrahim EM, Ezzat AA, Raja MA, Rahal MM, Ajarim DS, Mann B, Baloush A, Stuart RK, Bazarbashi SN. Ibrahim EM, et al. Among authors: ezzat aa. Ann Oncol. 1999 Dec;10(12):1441-9. doi: 10.1023/a:1008325823967. Ann Oncol. 1999. PMID: 10643534 Free article.

4

Phase II trial of chronic daily VP-16 administration in unresectable hepatocellular carcinoma (HCC).

Wierzbicki R, Ezzat A, Abdel-Warith A, Ayoub A, Kagevi I, Fadda M, Sieck J, Abdulkareem M, Amin T, Yazigi A, et al. Wierzbicki R, et al. Ann Oncol. 1994 May;5(5):466-7. doi: 10.1093/oxfordjournals.annonc.a058882. Ann Oncol. 1994. PMID: 8075054 Free article. Clinical Trial. No abstract available.

5

A phase II trial of circadian-timed paclitaxel and cisplatin therapy in metastatic breast cancer.

Ezzat A, Raja MA, Berry J, Bazarbashi S, Zwaan F, Rahal M, el-Warith A. Ezzat A, et al. Ann Oncol. 1997 Jul;8(7):663-7. doi: 10.1023/a:1008228121390. Ann Oncol. 1997. PMID: 9296219 Free article. Clinical Trial.

6

Effect of tamoxifen on the pharmacokinetics of doxorubicin in patients with non-Hodgkin's lymphoma.

El-Yazigi A, Berry J, Ezzat A, Wahab FA. El-Yazigi A, et al. Ther Drug Monit. 1997 Dec;19(6):632-6. doi: 10.1097/00007691-199712000-00005. Ther Drug Monit. 1997. PMID: 9421103 Clinical Trial.

7

A pilot trial of combination cisplatin, 5-fluorouracil and interferon-alpha in the treatment of advanced esophageal carcinoma.

Bazarbashi S, Rahal M, Raja MA, El Weshi A, Pai C, Ezzat A, Ajarim D, Memon M, Al Fadda M. Bazarbashi S, et al. Chemotherapy. 2002 Sep;48(4):211-6. doi: 10.1159/000063870. Chemotherapy. 2002. PMID: 12218269 Clinical Trial.

8

Phase II trial of cisplatin, 5-fluorouracil, and interferon-alpha-2B as first line treatment of advanced urothelial cancer.

Bazarbashi S, Pai C, Raja MA, Rahal M, Ezzat A, Hanash K. Bazarbashi S, et al. Urol Oncol. 2003 May-Jun;21(3):185-9. doi: 10.1016/s1078-1439(02)00204-1. Urol Oncol. 2003. PMID: 12810204 Clinical Trial.

9

VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors.

El Weshi A, Memon M, Raja M, Bazarbashi S, Rahal M, El Foudeh M, Pai C, Allam A, El Hassan I, Ezzat A. El Weshi A, et al. Am J Clin Oncol. 2004 Oct;27(5):529-34. doi: 10.1097/01.coc.0000135815.94162.83. Am J Clin Oncol. 2004. PMID: 15596925

10

Cryoglobulinaemia ten years before onset of lymphoma.

Ezzat AA, Raja MA, Eisa A, Furayh O. Ezzat AA, et al. Acta Oncol. 1994;33(1):69-70. doi: 10.3109/02841869409098379. Acta Oncol. 1994. PMID: 8142128 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters